TLR-Mediated Production of Reactive Oxygen Species and Tumor Necrosis Factor Alpha by Human Peripheral Blood Neutrophils

This paper presents the study on TLR-mediated production of reactive oxygen species and tumor necrosis factor alpha by peripheral blood neutrophils in healthy donors stimulated with zymosan (TLR2/6 ligand), peptidoglycan (TLR2/1 ligand), and lipopolysaccharide (TLR4 ligand). Luminol- and lucigen-ind...

Full description

Saved in:
Bibliographic Details
Published inBiophysics (Oxford) Vol. 63; no. 2; pp. 187 - 192
Main Authors Teselkin, Yu. O., Khoreva, M. V., Veselova, A. V., Babenkova, I. V., Osipov, A. N., Gankovskaya, L. V., Vladimirov, Yu. A.
Format Journal Article
LanguageEnglish
Published Moscow Pleiades Publishing 01.03.2018
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This paper presents the study on TLR-mediated production of reactive oxygen species and tumor necrosis factor alpha by peripheral blood neutrophils in healthy donors stimulated with zymosan (TLR2/6 ligand), peptidoglycan (TLR2/1 ligand), and lipopolysaccharide (TLR4 ligand). Luminol- and lucigen-independent chemiluminescence was used to detect the production of reactive oxygen species. The concentration of tumor necrosis factor alpha was measured by enzyme immunoassay. The plots of dependence of the light sums of luminol- and lucigenin-dependent chemiluminescence on the concentration of each ligand were shaped as saturation curves. The comparison of the light sums of lucigenin-dependent chemiluminescence (the production of superoxide anion radical) and luminol-dependent chemiluminescence (the total production of reactive oxygen species) showed that the contribution of NADPH oxidase to the total TLR-mediated production of oxidants can reach 40–50%. Stimulation indices were calculated to compare the ability of TLR ligands to stimulate the production of reactive oxygen species and tumor necrosis factor alpha by neutrophils. It has been established that the activation of neutrophils with zymosan leads to higher (more than 8-fold) production of reactive oxygen species rather than production of tumor necrosis factor alpha. Unlike zymosan, lipopolysaccharide stimulated the production of tumor necrosis factor alpha to a greater extent (by more than 2 times) than the production of reactive oxygen species. Peptidoglycan takes an intermediate position between these ligands. Thus, the production of effector molecules (reactive oxygen species and tumor necrosis factor alpha) by human peripheral blood neutrophils depends on the nature of the TRL ligand.
AbstractList This paper presents the study on TLR-mediated production of reactive oxygen species and tumor necrosis factor alpha by peripheral blood neutrophils in healthy donors stimulated with zymosan (TLR2/6 ligand), peptidoglycan (TLR2/1 ligand), and lipopolysaccharide (TLR4 ligand). Luminol- and lucigen-independent chemiluminescence was used to detect the production of reactive oxygen species. The concentration of tumor necrosis factor alpha was measured by enzyme immunoassay. The plots of dependence of the light sums of luminol- and lucigenin-dependent chemiluminescence on the concentration of each ligand were shaped as saturation curves. The comparison of the light sums of lucigenin-dependent chemiluminescence (the production of superoxide anion radical) and luminol-dependent chemiluminescence (the total production of reactive oxygen species) showed that the contribution of NADPH oxidase to the total TLR-mediated production of oxidants can reach 40–50%. Stimulation indices were calculated to compare the ability of TLR ligands to stimulate the production of reactive oxygen species and tumor necrosis factor alpha by neutrophils. It has been established that the activation of neutrophils with zymosan leads to higher (more than 8-fold) production of reactive oxygen species rather than production of tumor necrosis factor alpha. Unlike zymosan, lipopolysaccharide stimulated the production of tumor necrosis factor alpha to a greater extent (by more than 2 times) than the production of reactive oxygen species. Peptidoglycan takes an intermediate position between these ligands. Thus, the production of effector molecules (reactive oxygen species and tumor necrosis factor alpha) by human peripheral blood neutrophils depends on the nature of the TRL ligand.
Author Vladimirov, Yu. A.
Osipov, A. N.
Veselova, A. V.
Gankovskaya, L. V.
Teselkin, Yu. O.
Khoreva, M. V.
Babenkova, I. V.
Author_xml – sequence: 1
  givenname: Yu. O.
  surname: Teselkin
  fullname: Teselkin, Yu. O.
  email: teselkin-box@mail.ru
  organization: Pirogov Russian National Research Medical University
– sequence: 2
  givenname: M. V.
  surname: Khoreva
  fullname: Khoreva, M. V.
  organization: Pirogov Russian National Research Medical University
– sequence: 3
  givenname: A. V.
  surname: Veselova
  fullname: Veselova, A. V.
  organization: Pirogov Russian National Research Medical University
– sequence: 4
  givenname: I. V.
  surname: Babenkova
  fullname: Babenkova, I. V.
  organization: Pirogov Russian National Research Medical University
– sequence: 5
  givenname: A. N.
  surname: Osipov
  fullname: Osipov, A. N.
  organization: Pirogov Russian National Research Medical University
– sequence: 6
  givenname: L. V.
  surname: Gankovskaya
  fullname: Gankovskaya, L. V.
  organization: Pirogov Russian National Research Medical University
– sequence: 7
  givenname: Yu. A.
  surname: Vladimirov
  fullname: Vladimirov, Yu. A.
  organization: Pirogov Russian National Research Medical University
BookMark eNp1kE9PwkAQxTcGEwH9AN428Vzdv-32iETEBIUAnpttO4WS0q271MC3dysmHoynmcn7vTeZGaBebWpA6JaSe0q5eFgRQkIuSUwVYYSx6AL1qZQyCEMpeqjfyUGnX6GBcztCqCBC9tFxPVsGr5CX-gA5XliTt9mhNDU2BV6C9v0n4PnxtIEarxrISnBY1zlet3tj8Rtk1rjS4Ykn_Tyqmq3G6QlP272u8QJs2WzB6go_Vsbknm8P1jTbsnLX6LLQlYObnzpE75On9XgazObPL-PRLMgYp1HAIsozQUkq0gyAcZILBULxKGQqjtMizSIdh1meq4IyrTgRqWAQs-_7UgF8iO7OuY01Hy24Q7Izra39yoQRqZSKZCg8Rc9Ud4-zUCSNLffanhJKku7ByZ8Hew87e5xn6w3Y3-T_TV_6CX35
CitedBy_id crossref_primary_10_3390_ijms21103452
Cites_doi 10.1134/S000635090601012X
10.1159/000102054
10.4049/jimmunol.173.6.3589
10.1007/s12272-016-0806-9
10.1155/2010/916425
10.1016/j.molimm.2003.10.005
10.3109/08830185.2013.777065
10.1189/jlb.0804442
10.1007/s11684-015-0412-0
10.1007/s00705-016-2904-x
10.1152/ajpheart.00812.2005
10.1371/journal.pone.0027828
10.1134/S0006297909130082
10.1152/ajpheart.00995.2008
10.4291/wjgp.v5.i3.133
10.1124/pr.114.010090
10.1016/j.cbi.2013.08.010
10.1084/jem.20021787
10.1038/ni1116
10.1016/0076-6879(86)33085-4
10.1016/S0145-305X(02)00023-X
10.1016/j.intimp.2013.06.034
10.1182/blood-2003-04-1078
10.1016/j.bcp.2012.10.010
10.1007/s10517-014-2561-6
ContentType Journal Article
Copyright Pleiades Publishing, Inc. 2018
Biophysics is a copyright of Springer, (2018). All Rights Reserved.
Copyright_xml – notice: Pleiades Publishing, Inc. 2018
– notice: Biophysics is a copyright of Springer, (2018). All Rights Reserved.
DBID AAYXX
CITATION
3V.
7QP
7QR
7X7
7XB
88A
88E
88I
8AO
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
P64
PQEST
PQQKQ
PQUKI
PRINS
Q9U
DOI 10.1134/S0006350918020227
DatabaseName CrossRef
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
AUTh Library subscriptions: ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest Science Journals
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
DatabaseTitle CrossRef
ProQuest Central Student
Technology Research Database
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
Chemoreception Abstracts
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest Central (Alumni)
DatabaseTitleList ProQuest Central Student

Database_xml – sequence: 1
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
Physics
EISSN 1555-6654
EndPage 192
ExternalDocumentID 10_1134_S0006350918020227
GroupedDBID --K
-5F
-5G
-BR
-EM
-Y2
-~C
-~X
.GJ
.VR
06D
0R~
0VY
1B1
1N0
23N
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
3O-
3V.
4.4
408
40D
40E
53G
5RE
5VS
6J9
6NX
78A
7X7
88A
88E
88I
8AO
8FE
8FH
8FI
8FJ
8TC
95-
95.
95~
96X
AAAVM
AABHQ
AAFGU
AAHNG
AAIAL
AAJKR
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABDZT
ABECU
ABEFU
ABFGW
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACGOD
ACHSB
ACHXU
ACIGE
ACIPQ
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACREN
ACSNA
ACTTH
ACVWB
ACWMK
ADBBV
ADFRT
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEOHA
AEPYU
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFFNX
AFGCZ
AFKRA
AFLOW
AFNRJ
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGBP
AGJBK
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBNVY
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
DU5
DWQXO
EBLON
EBS
EIOEI
EJD
ESBYG
F5P
FD6
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
HCIFZ
HF~
HG6
HLICF
HMCUK
HMJXF
HRMNR
HVGLF
HZ~
H~9
IHE
IJ-
IKXTQ
IWAJR
IXD
I~X
I~Z
J-C
JBSCW
JZLTJ
KOV
L7B
LK8
LLZTM
M0L
M1P
M2P
M41
M4Y
M7P
MA-
N2Q
N9A
NB0
NPVJJ
NQ-
NQJWS
NU0
O9-
O93
O9J
P9T
PF0
PQQKQ
PROAC
PSQYO
PT4
Q2X
QOS
R89
R9I
RIG
RNS
ROL
RPZ
RSV
S16
S1Z
S27
S3B
SAP
SDH
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPH
SPISZ
SRMVM
SSLCW
STPWE
SZN
T13
TKC
TSG
TUC
UG4
UKHRP
UNUBA
UOJIU
UPT
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WIP
WK8
XPP
XU3
YLTOR
ZGI
ZMTXR
ZXP
~A9
AACDK
AAJBT
AASML
AAYXX
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGRTI
AIGIU
ALIPV
CITATION
7QP
7QR
7XB
8FD
8FK
FR3
K9.
P64
PQEST
PQUKI
PRINS
Q9U
ID FETCH-LOGICAL-c2317-2713c410b4bcee230d48e483762899bfbc7a96cdd8f12a8304b42e9201404b4e3
IEDL.DBID AGYKE
ISSN 0006-3509
IngestDate Fri Sep 13 08:11:07 EDT 2024
Thu Sep 12 17:54:10 EDT 2024
Sat Dec 16 12:02:17 EST 2023
IsPeerReviewed false
IsScholarly false
Issue 2
Keywords Toll-like receptors
ligands
tumor necrosis factor alpha
neutrophils
chemiluminescence
reactive oxygen species
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2317-2713c410b4bcee230d48e483762899bfbc7a96cdd8f12a8304b42e9201404b4e3
PQID 2058887564
PQPubID 55444
PageCount 6
ParticipantIDs proquest_journals_2058887564
crossref_primary_10_1134_S0006350918020227
springer_journals_10_1134_S0006350918020227
PublicationCentury 2000
PublicationDate 2018-03-01
PublicationDateYYYYMMDD 2018-03-01
PublicationDate_xml – month: 03
  year: 2018
  text: 2018-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Moscow
PublicationPlace_xml – name: Moscow
PublicationTitle Biophysics (Oxford)
PublicationTitleAbbrev BIOPHYSICS
PublicationYear 2018
Publisher Pleiades Publishing
Springer Nature B.V
Publisher_xml – name: Pleiades Publishing
– name: Springer Nature B.V
References SheppardF. R.KelherM. R.MooreE. E.J. Leukoc. Biol.200578102510.1189/jlb.0804442
ParkH. S.JungH. Y.ParkE. Y.J. Immunol.2004173358910.4049/jimmunol.173.6.3589
GantnerB. N.SimmonsR. M.CanaveraS. J.J. Exp. Med.2003197110710.1084/jem.20021787
BeutlerB.Mol. Immunol.20044084510.1016/j.molimm.2003.10.005
Abdul-CaderM. S.AmarasingheA.Abdul-CareemM. F.Arch. Virol.2016161207510.1007/s00705-016-2904-x
ZhuL.HeP.Am. J. Physiol. Heart Circ. Physiol.20062901H36510.1152/ajpheart.00812.2005
KohchiC.InagawaH.NishizawaT.SomaG.Anticancer Res.200929817
VladimirovY. A.ProskurninaE. V.Biochemistry (Moscow)200974154510.1134/S0006297909130082
PlatoA.WillmentJ. A.BrownG. D.Int. Rev. Immunol.20133213410.3109/08830185.2013.777065
ChaoW.Am. J. Physiol. Heart Circ. Physiol.2009296H110.1152/ajpheart.00995.2008
CannovaJ.BreslinS. J. P.ZhangJ.Front. Med.2015928810.1007/s11684-015-0412-0
Microbiol. Spectr.201644
ItouT.ShojiY.ShiraishiR.Dev. Comp. Immunol.200226767510.1016/S0145-305X(02)00023-X
Makni-MaalejK.ChiandottoM.Hurtado-NedelecM.Biochem. Pharmacol.2013859210.1016/j.bcp.2012.10.010
GoulopoulouS.McCarthyC. G.WebbR. C.Pharmacol. Rev.20166814210.1124/pr.114.010090
PiryazevA. P.AzizovaA. P.AseichevA. V.SergienkoV. I.Bull. Exp. Biol. Med.201415734110.1007/s10517-014-2561-6
SmithS. M.World J. Gastrointest. Pathophysiol.2014513310.4291/wjgp.v5.i3.133
DahiyaY.PandeyR. K.SodhiA.PLoS One20116e278282011PLoSO...627828D10.1371/journal.pone.0027828
FleerA.KredietT. G.Neonatology20079214510.1159/000102054
AchekA.YesudhasD.ChoiS.Arch. Pharm. Res.201639103210.1007/s12272-016-0806-9
KabeyaL. M.FuzissakiC. N.Taleb-ContiniS. H.Chem. Biol. Interact.20132066310.1016/j.cbi.2013.08.010
XiangM.FanJ.FanJ.Mediators Inflamm.2010201091642510.1155/2010/916425
RoshchupkinD. I.BelakinaN. S.MurinaM. A.Biophysics (Moscow)20065117910.1134/S000635090601012X
FutosiK.FodorS.MocsaiA.Int. Immunopharmacol.20131763810.1016/j.intimp.2013.06.034
HayashiF.MeansT. K.LusterA. D.Blood.2003102266010.1182/blood-2003-04-1078
AllenR. C.Methods Enzymol.198613344910.1016/0076-6879(86)33085-4
CookD. N.PisetskyD. S.SchwartzD. A.Nat. Immunol.2004597510.1038/ni1116
S. Goulopoulou (8366_CR10) 2016; 68
F. Hayashi (8366_CR18) 2003; 102
D. I. Roshchupkin (8366_CR25) 2006; 51
D. N. Cook (8366_CR1) 2004; 5
Y. Dahiya (8366_CR19) 2011; 6
C. Kohchi (8366_CR2) 2009; 29
K. Futosi (8366_CR3) 2013; 17
M. S. Abdul-Cader (8366_CR5) 2016; 161
R. C. Allen (8366_CR20) 1986; 133
L. Zhu (8366_CR17) 2006; 290
L. M. Kabeya (8366_CR21) 2013; 206
Y. A. Vladimirov (8366_CR23) 2009; 74
J. Cannova (8366_CR4) 2015; 9
M. Xiang (8366_CR7) 2010; 2010
H. S. Park (8366_CR13) 2004; 173
(8366_CR15) 2016; 4
B. N. Gantner (8366_CR27) 2003; 197
B. Beutler (8366_CR11) 2004; 40
S. M. Smith (8366_CR8) 2014; 5
F. R. Sheppard (8366_CR24) 2005; 78
W. Chao (8366_CR6) 2009; 296
A. Achek (8366_CR9) 2016; 39
K. Makni-Maalej (8366_CR14) 2013; 85
T. Itou (8366_CR16) 2002; 26
A. Fleer (8366_CR12) 2007; 92
A. P. Piryazev (8366_CR22) 2014; 157
A. Plato (8366_CR26) 2013; 32
References_xml – volume: 51
  start-page: 79
  issue: 1
  year: 2006
  ident: 8366_CR25
  publication-title: Biophysics (Moscow)
  doi: 10.1134/S000635090601012X
  contributor:
    fullname: D. I. Roshchupkin
– volume: 92
  start-page: 145
  year: 2007
  ident: 8366_CR12
  publication-title: Neonatology
  doi: 10.1159/000102054
  contributor:
    fullname: A. Fleer
– volume: 173
  start-page: 3589
  year: 2004
  ident: 8366_CR13
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.173.6.3589
  contributor:
    fullname: H. S. Park
– volume: 39
  start-page: 1032
  year: 2016
  ident: 8366_CR9
  publication-title: Arch. Pharm. Res.
  doi: 10.1007/s12272-016-0806-9
  contributor:
    fullname: A. Achek
– volume: 2010
  start-page: 916425
  year: 2010
  ident: 8366_CR7
  publication-title: Mediators Inflamm.
  doi: 10.1155/2010/916425
  contributor:
    fullname: M. Xiang
– volume: 40
  start-page: 845
  year: 2004
  ident: 8366_CR11
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2003.10.005
  contributor:
    fullname: B. Beutler
– volume: 32
  start-page: 134
  year: 2013
  ident: 8366_CR26
  publication-title: Int. Rev. Immunol.
  doi: 10.3109/08830185.2013.777065
  contributor:
    fullname: A. Plato
– volume: 78
  start-page: 1025
  year: 2005
  ident: 8366_CR24
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.0804442
  contributor:
    fullname: F. R. Sheppard
– volume: 9
  start-page: 288
  year: 2015
  ident: 8366_CR4
  publication-title: Front. Med.
  doi: 10.1007/s11684-015-0412-0
  contributor:
    fullname: J. Cannova
– volume: 161
  start-page: 2075
  year: 2016
  ident: 8366_CR5
  publication-title: Arch. Virol.
  doi: 10.1007/s00705-016-2904-x
  contributor:
    fullname: M. S. Abdul-Cader
– volume: 290
  start-page: H365
  issue: 1
  year: 2006
  ident: 8366_CR17
  publication-title: Am. J. Physiol. Heart Circ. Physiol.
  doi: 10.1152/ajpheart.00812.2005
  contributor:
    fullname: L. Zhu
– volume: 6
  start-page: e27828
  year: 2011
  ident: 8366_CR19
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0027828
  contributor:
    fullname: Y. Dahiya
– volume: 29
  start-page: 817
  year: 2009
  ident: 8366_CR2
  publication-title: Anticancer Res.
  contributor:
    fullname: C. Kohchi
– volume: 74
  start-page: 1545
  year: 2009
  ident: 8366_CR23
  publication-title: Biochemistry (Moscow)
  doi: 10.1134/S0006297909130082
  contributor:
    fullname: Y. A. Vladimirov
– volume: 296
  start-page: H1
  year: 2009
  ident: 8366_CR6
  publication-title: Am. J. Physiol. Heart Circ. Physiol.
  doi: 10.1152/ajpheart.00995.2008
  contributor:
    fullname: W. Chao
– volume: 5
  start-page: 133
  year: 2014
  ident: 8366_CR8
  publication-title: World J. Gastrointest. Pathophysiol.
  doi: 10.4291/wjgp.v5.i3.133
  contributor:
    fullname: S. M. Smith
– volume: 68
  start-page: 142
  year: 2016
  ident: 8366_CR10
  publication-title: Pharmacol. Rev.
  doi: 10.1124/pr.114.010090
  contributor:
    fullname: S. Goulopoulou
– volume: 206
  start-page: 63
  year: 2013
  ident: 8366_CR21
  publication-title: Chem. Biol. Interact.
  doi: 10.1016/j.cbi.2013.08.010
  contributor:
    fullname: L. M. Kabeya
– volume: 197
  start-page: 1107
  year: 2003
  ident: 8366_CR27
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20021787
  contributor:
    fullname: B. N. Gantner
– volume: 5
  start-page: 975
  year: 2004
  ident: 8366_CR1
  publication-title: Nat. Immunol.
  doi: 10.1038/ni1116
  contributor:
    fullname: D. N. Cook
– volume: 133
  start-page: 449
  year: 1986
  ident: 8366_CR20
  publication-title: Methods Enzymol.
  doi: 10.1016/0076-6879(86)33085-4
  contributor:
    fullname: R. C. Allen
– volume: 4
  issue: 4
  year: 2016
  ident: 8366_CR15
  publication-title: Microbiol. Spectr.
– volume: 26
  start-page: 675
  issue: 7
  year: 2002
  ident: 8366_CR16
  publication-title: Dev. Comp. Immunol.
  doi: 10.1016/S0145-305X(02)00023-X
  contributor:
    fullname: T. Itou
– volume: 17
  start-page: 638
  year: 2013
  ident: 8366_CR3
  publication-title: Int. Immunopharmacol.
  doi: 10.1016/j.intimp.2013.06.034
  contributor:
    fullname: K. Futosi
– volume: 102
  start-page: 2660
  year: 2003
  ident: 8366_CR18
  publication-title: Blood.
  doi: 10.1182/blood-2003-04-1078
  contributor:
    fullname: F. Hayashi
– volume: 85
  start-page: 92
  year: 2013
  ident: 8366_CR14
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/j.bcp.2012.10.010
  contributor:
    fullname: K. Makni-Maalej
– volume: 157
  start-page: 341
  year: 2014
  ident: 8366_CR22
  publication-title: Bull. Exp. Biol. Med.
  doi: 10.1007/s10517-014-2561-6
  contributor:
    fullname: A. P. Piryazev
SSID ssj0014045
Score 1.7238662
Snippet This paper presents the study on TLR-mediated production of reactive oxygen species and tumor necrosis factor alpha by peripheral blood neutrophils in healthy...
SourceID proquest
crossref
springer
SourceType Aggregation Database
Publisher
StartPage 187
SubjectTerms Biological and Medical Physics
Biophysics
Cell activation
Cell Biophysics
Chemiluminescence
Enzyme immunoassay
Leukocytes (neutrophilic)
Ligands
Lipopolysaccharides
NAD(P)H oxidase
Necrosis
Neutrophils
Oxidants
Oxidation
Peptidoglycans
Peripheral blood
Physics
Physics and Astronomy
Reactive oxygen species
Superoxide
TLR2 protein
TLR4 protein
Toll-like receptors
Tumor necrosis factor-TNF
Tumor necrosis factor-α
SummonAdditionalLinks – databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFA5zIvgiXnHeyINPSrBNT29PMmVjiJtjbOBbSdIUhbnOXcD9e0_S1omizy2hPSfJd-4fIZdcgZcBCJZykTGEAJ8JPxJMx2HGBRcQCNPv3O0FnRE8PPvPNdKpemFMWWV1J9qLOs2ViZGjk-6jsxb6AdwIaaIAanFzO31nhj_K5FlLMo0NssldMAnbzbtWrz_4yiiAAwWbgan1QpQsM5yuB6ZbGIHaIGeExhM3BDPfMWpteP7IlVoIau-SndJ2pM1C2Xukpif7ZKtgk1wdkI_h44B1LfWGTmm_GOWKYqd5Rgda2IuNPn2scMtQSzuv51RMUjpcvuUz2tPmY17ntG0ZeGjTNOFSuaI2zE_7uFPtBIIxvTO17vj-cjHLpy-v4_khGbVbw_sOK4kVmEJzLmQcPVMFriNBIkaiE5JCpM1o-cC4XzKTKhRxoNI0ylwuIs8BCVzH3EpRgvaOSH2ST_QxoYESMfjSCeMIwOcyAoU2T-bLMFUud4IGuapEmUyL-RmJ9Ts8SH7JvUHOKmEn5VGaJ2vFN8h1pYD14z8XO_l_sVOyjf8TFeVkZ6S-mC31OdoXC3lRbp1PwzXKxw
  priority: 102
  providerName: ProQuest
Title TLR-Mediated Production of Reactive Oxygen Species and Tumor Necrosis Factor Alpha by Human Peripheral Blood Neutrophils
URI https://link.springer.com/article/10.1134/S0006350918020227
https://www.proquest.com/docview/2058887564/abstract/
Volume 63
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dT9swED9BEdJeYBubVmDID3tiSpW65zh5LKgFbaNUVZG6p8h2HA0BKWpaifLXc3ZS0Ph44CmR4lhy7uL7ne_jB_CDG-zkiCrIuMoDMgEiUCJWgU1kzhVXGClX73w2iE4v8NdETNaAPx5dFFetVUTSb9QV7Qi6kl6yps68xYRwOJfrsCEcK3UDNronf3_3HmMHGGLFW-CyuuiFOpb56iT_W6MniPksKuqNTX-7KgAsfY9Cl2Ny1VrMdcvcv-zg-I51fIStGnuybqUsn2DNFp9hs2KjXNKdzwY15Q7cjf-MgjNP4mEzNqyawpIA2TRnI6v8FsnO75akfMwT2NuSqSJj48XNdMYG1i32smR9z-XDuq6cl-kl8wEDNiSd970MrtmRy5qn8Yv5bHr77_K6_AIX_d74-DSoKRoCQ8BQBpx8XIPtUKMma0vuTIaxdU3qI-fI6VwbqZLIZFmct7mKOyFq5DbhXkoabecrNIppYb8Bi4xKUOhQJjGi4DpGQ-gpF1pmps3DqAmHK1Glt1UnjtR7MB1MX3zUJuyvhJnWP2WZ8lCQvy9FhE34uRLO0-M3J9t91-g9-EDLi6s8tX1ozGcL-52Ay1wfwLqcyINaX-l61BsMRw9J-uKj
link.rule.ids 315,786,790,12083,21416,27957,27958,31754,33779,41116,42185,43345,43840,52146
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEA5aEb2IT6xWzcGTEmizs6-TVLFUbWuRCr0tSTaLhdqt3Rbaf-8ku7Wi6HmXsDt5fPPNTOYj5JIrcBIAwWIuEoYQ4DLhBoLp0E-44AI8Ye47tzte8xUe-26_CLhlRVnl8ky0B3WcKhMjR5LuIlnzXQ9uxh_MqEaZ7GohobFONsBxwJT0-f0vwmU6x-QKBqa-C5GxyGrWHDA3hBGcDVoG6DBxIyrzHZdWzuaP_KiFncYu2Sn8RVrPJ3iPrOnRPtnMFSQXB2Tea72wtpXb0DHt5u1b0dQ0TeiLFvYwo8_zBS4TaqXmdUbFKKa92Xs6oR1tPmaQ0YZV3aF1c_GWygW1oX3axdVpuw4M6a2pb8f3Z9NJOn4bDLND8tq47901WSGmwBS6cD7jyEYV1KoSJOIiEo8YAm3ayXuGcslEKl-EnorjIKlxEThVkMB1yK0VJWjniJRG6UgfE-opEYIrq34YALhcBqDQz0lc6ceqxqtemVwtTRmN854ZkeUaDkS_7F4mlaWxo2L7ZNFqssvkejkBq8d_Dnby_2AXZKvZa7ei1kPn6ZRs478FeTlZhZSmk5k-Q_9iKs_tIvoEyjnIlA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dT9swED9tICZe2PiY6GDDDzyBAql7SZzHbqPjs1SoSPCU2Y4jECytmlSi--t3dpKhAXuY9hYpjpXz3fnudB8_gG2usZMhSi_lMvPIBASeDIT0TBxlXHKJobT9zmf98PASj6-CqxrntGiq3ZuUZNXTYKc05eX-OM1qDBK0_b1kWq2tE-TucB69hnkkrSURn-9-uz45-J1IQB8rEANb4kUf1InNFzf50zQ9-ptPUqTO8vTewvfmn6uCk7u9aan29M8n4xz_g6h3sFR7paxbidEyvDL5CixUOJUzenJ1orpYhYfh6YV35uA9TMoG1bhYYi0bZezCSHd5svOHGYklc9D2pmAyT9lw-mM0YX1jKb8tWM-h_LCubfRlasZcKoENSBvclIN79tnW09P6aTkZjW9u74s1uOwdDL8cejV4g6fJZYw8TtGvxravUJEdpkAnRWHs-PrQhngqUzqScajTVGRtLkXHR4XcxNyxTKHpvIe5fJSbdWChljEGyo9igRhwJVCTX5UFKkp1m_thC3YaviXjakZH4mKbDibPDrUFmw1nk1pdi4T7gaDbNgixBbsNox5f_3WzD_-0egveDL72ktOj_skGLBKloipm24S5cjI1H8m7KdWnWoJ_ATKV7NE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TLR-Mediated+Production+of+Reactive+Oxygen+Species+and+Tumor+Necrosis+Factor+Alpha+by+Human+Peripheral+Blood+Neutrophils&rft.jtitle=Biophysics+%28Oxford%29&rft.au=Teselkin%2C+Yu.+O.&rft.au=Khoreva%2C+M.+V.&rft.au=Veselova%2C+A.+V.&rft.au=Babenkova%2C+I.+V.&rft.date=2018-03-01&rft.issn=0006-3509&rft.eissn=1555-6654&rft.volume=63&rft.issue=2&rft.spage=187&rft.epage=192&rft_id=info:doi/10.1134%2FS0006350918020227&rft.externalDBID=n%2Fa&rft.externalDocID=10_1134_S0006350918020227
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-3509&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-3509&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-3509&client=summon